Dec 5, 2023Japanese patent awarded to hInGeTox safety assayTestAVec's hInGeTox saftey assay has been awarded a patent from Japan. Two of TestAVec's key saftey tests, hInGeTox and DiNARep, have now...
Oct 31, 2023TestAVec at ESGCT 2023TestAVec went to the 30th ESGCT Congress, this year held in the beautiful city of Brussels. Robert, Mike and Saqlain attended the...
May 12, 2022TestAVec Researchers Uncover Possible Reasons For Side Effects of HIV-1 Lentiviral VectorsTestAVec CSO, Professor Michael Themis, also Head of the Gene Therapy research group at Brunel University London, and his team have...
Dec 24, 2021Merry Christmas from TestAVecFrom all of us at TestAVec, we wish you a wonderful Christmas and new year. We look forward to working with you in 2022.
Dec 9, 2021The real patient benefit of gene therapy highlighted by skin transplantIn 2015, a 7 year old patient was presented at a hospital in Germany with severe burns. The patient had suffered debilitating blisters...